Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Katherine Medley"'
Autor:
Yasmine Anouty, Ila M. Saunders, Shanna Block, Katherine Medley, Rabia S. Atayee, Megan Wall, Alison Wall, Carolyn Mulroney, Janine Martino
Publikováno v:
Journal of Clinical Pathways. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db61b175aae70156b795fe286dc73f49
https://doi.org/10.25270/jcp.2022.02.2
https://doi.org/10.25270/jcp.2022.02.2
Autor:
Halle Cheplowitz, Nimish Patel, Alexander Kim, Cathy Logan, Nancy Law, Divya Koura, Nina Haste, Katherine Medley, Julie Trinh, Tyler Sanders, Mahnaz Taremi, Ila M Saunders
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311657
Current guidelines for vaccination in allogeneic hematopoietic stem cell transplant (HCT) recipients recommend initiation of pneumococcal vaccination series three to six months post-HCT, with most data supporting initiation at six months due to a mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::174d70987e2fec672e21928d2248b987
https://doi.org/10.1177/10781552231165733
https://doi.org/10.1177/10781552231165733
Publikováno v:
Open Forum Infectious Diseases
Background Allogeneic hematopoietic stem cell transplantation (HSCT) is a valuable treatment option for patients with some blood/malignant disorders. However, this procedure may be complicated by life-threatening infections, including invasive asperg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa8f451709ef42886b43084067210b92
https://doi.org/10.1093/ofid/ofy210.1711
https://doi.org/10.1093/ofid/ofy210.1711
Publikováno v:
Journal of Oncology Pharmacy Practice. 17:85-90
There was no consensus on the optimal use of G-CSF after hematopoietic stem cell transplantation. In this study, the practice of using G-CSF, based on the CD34+ cell number, at the University of California, San Diego Blood and Marrow Transplant Unit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6838f58121e93a2825cdb044cadc1e5c
https://doi.org/10.1177/1078155209354932
https://doi.org/10.1177/1078155209354932
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(2)
s / Biol Blood Marrow Transplant 21 (2015) S240eS265 S259 88.88% were walking
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bbbeb71f85cd3641d4e49a907c6688
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(2):S251-S252
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e1bdea4b721dc307dfb650605de6a4
Publikováno v:
Bone marrow transplantation. 43(12)
After hematopoietic SCT (HSCT), G-CSF is commonly used to enhance stem cell engraftment to minimize the morbidity and mortality associated with prolonged neutropenia. However, there is no consensus on the optimal use of G-CSF after high-dose chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f88ff7896a8f33cba4ff5f9aca95378
https://pubmed.ncbi.nlm.nih.gov/19363527
https://pubmed.ncbi.nlm.nih.gov/19363527
Publikováno v:
Biology of Blood and Marrow Transplantation. (2):S251
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45521935dabc46b4644220bcb8f799e3
Autor:
Cheplowitz, Halle, Patel, Nimish, Kim, Alexander, Logan, Cathy, Law, Nancy, Koura, Divya, Haste, Nina, Medley, Katherine, Trinh, Julie, Sanders, Tyler, Taremi, Mahnaz, Saunders, Ila M
Publikováno v:
Journal of Oncology Pharmacy Practice; Jan2024, Vol. 30 Issue 1, p15-18, 4p
Publikováno v:
Pharmacotherapy; Jul2012, Vol. 32 Issue 7, p596-603, 8p